Catalyst Event

Voronoi Inc (310210) · Earnings Release

From KRX Bio Technology Transfer Index (KBIOTT)

3/19/2026, 12:00:00 AM

Earnings ReleaseSentiment: Neutral

Released FY2025 earnings on March 19, 2026, reporting an operating loss consistent with its status as a pre-revenue, R&D-focused biotechnology company. As the results align with expectations for a development-stage company, a price impact of at least 1% is expected.

Korean Translation

2026년 3월 19일, 2025년 회계연도 실적을 발표했으며, 연구개발 중심의 비매출 바이오 기술 기업으로서의 현황과 일치하는 영업손실을 보고함. 예상치에 부합하는 실적으로 1% 이상의 주가 영향이 예상됨.

Related Recent Events

View Full Timeline